Global Cord Blood posts JPLs Sixteenth Report
Global Cord Blood Corporation, a Cayman Islands company under court-appointed joint provisional liquidation, filed an update about its restructuring process.
Rhea-AI Filing Summary
Global Cord Blood Corporation, a Cayman Islands company under court-appointed joint provisional liquidation, filed an update about its restructuring process. The Grand Court of the Cayman Islands appointed joint provisional liquidators on September 22, 2022 under Section 104(2) of the Companies Act.
On June 1, 2026, the joint provisional liquidators furnished their sixteenth report to the Court. The report is available on the company’s investor relations website and on Grant Thornton’s creditor update page. The company also lists a regular schedule of earlier reports furnished since October 2022, indicating ongoing court-supervised oversight.
Positive
- None.
Negative
- None.
Key Figures
Commission File Number: 001-34541
JPL appointment date: September 22, 2022
Companies Act section: Section 104(2)
+3 more
6 metrics
Commission File Number
001-34541
SEC registration identifier
JPL appointment date
September 22, 2022
Grand Court of the Cayman Islands order appointing JPLs
Companies Act section
Section 104(2)
Cayman Islands Companies Act basis for JPL appointment
Sixteenth Report date
June 1, 2026
Date JPLs furnished sixteenth report to the Court
Form type
Form 6-K
Report of foreign private issuer for June 2026
Report signing date
June 4, 2026
Date 6-K was signed by joint provisional liquidator
Key Terms
joint provisional liquidators, Companies Act (as amended) of the Cayman Islands, foreign private issuer, Form 20-F, +2 more
6 terms
joint provisional liquidators regulatory
"the Grand Court of the Cayman Islands ... appointing ... as joint provisional liquidators (the “JPLs”)"
Joint provisional liquidators are temporary, court-appointed officials who take control of a troubled company's assets and affairs while a formal winding-up or insolvency process is being decided. Think of them as emergency guardians who stop value being lost, secure records, and assess whether creditors or shareholders can recover funds. Investors pay attention because their appointment usually signals serious financial distress, potential suspension of trading, and uncertainty about how much, if anything, will be repaid.
Companies Act (as amended) of the Cayman Islands regulatory
"pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ⌧"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Grand Court of the Cayman Islands regulatory
"the Grand Court of the Cayman Islands (the “Court”) issued an order appointing"
creditor update financial
"as well as on the GT Creditor Update Page"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Global Cord Blood Corporation (CORBF) report in this June 2026 6-K?
Global Cord Blood reports that its joint provisional liquidators submitted their sixteenth report to the Cayman court on June 1, 2026. The filing mainly informs investors and creditors that this report is available on the company’s website and Grant Thornton’s creditor update page.
Why does Global Cord Blood Corporation (CORBF) have joint provisional liquidators?
The Grand Court of the Cayman Islands appointed joint provisional liquidators for Global Cord Blood on September 22, 2022 under Section 104(2) of the Companies Act. This appointment places the company’s affairs under court-supervised oversight while its situation is assessed and managed by the liquidators.
Where can investors find the JPLs’ Sixteenth Report for Global Cord Blood (CORBF)?
The sixteenth report by the joint provisional liquidators is available on Global Cord Blood’s investor relations website and on Grant Thornton’s creditor update page. The 6-K provides direct URLs so stakeholders can access the detailed report outside the SEC filing.
How frequently have Global Cord Blood’s joint provisional liquidators reported to the court?
Since their appointment in September 2022, the joint provisional liquidators have furnished reports roughly every few months. The 6-K lists prior report dates in October and December 2022, and in March, June, September, and December of subsequent years through December 2025 and March 2026.
Does this Global Cord Blood (CORBF) 6-K include financial results or earnings data?
The 6-K does not present financial or earnings data. It focuses on procedural information about the company’s court-supervised provisional liquidation, specifically noting that the joint provisional liquidators’ sixteenth report has been filed with the court and made available online.
AI-generated analysis. How Rhea-AI works. Not financial advice.
